NCT06706115

Brief Summary

The aim of the study was to investigate the effect of intranasal breast milk administration on cerebral oxygenation level, vital signs and time to full oral feeding in preterm infants.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Jun 2024

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 21, 2024

Completed
1 month until next milestone

Study Start

First participant enrolled

June 30, 2024

Completed
5 months until next milestone

First Posted

Study publicly available on registry

November 26, 2024

Completed
10 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 15, 2025

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2025

Completed
Last Updated

November 26, 2024

Status Verified

November 1, 2024

Enrollment Period

1.2 years

First QC Date

May 21, 2024

Last Update Submit

November 22, 2024

Conditions

Keywords

Breast milkNewborn NursingOral NutritionPhysiological parametersPreterm infant

Outcome Measures

Primary Outcomes (6)

  • Infant Information Form

    The form developed by the researchers in line with the literature includes the identifying information of the preterm infant (gender, date of birth, gestational week at birth, mode of delivery, APGAR score, birth weight, postmenstrual age)

    First measurement-First day of hospitalization

  • Physiologic Parameter Follow-up Form-Cerebral rSO2

    Cerebral rSO2 in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.

    First measurement- 5 minutes before the intervention (T0)

  • Physiologic Parameter Follow-up Form-Oxygen saturation (sPO2)

    Oxygen saturation (sPO2) in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.

    First measurement- 5 minutes before the intervention (T0)

  • Physiologic Parameter Follow-up Form-Heart Rate (HR)

    Heart rate in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.

    First measurement- 5 minutes before the intervention (T0)

  • Physiologic Parameter Follow-up Form-Respiratory rate

    Respiratory rate in the Physiological Parameter Monitoring Form will be measured 5 minutes before the intervention.

    First measurement- 5 minutes before the intervention (T0)

  • Nutrition Follow-up Form-intranasal breast milk content

    Intranasal breast milk content (fresh/thawed) in the Nutrition Follow-up Form will be recorded before the intervention.

    First measurement- intranasal breast milk content

Secondary Outcomes (17)

  • Physiologic Parameter Follow-up Form -Cerebral rSO2

    Second measurement- 5. minutes after the intervention (T1)

  • Physiologic Parameter Follow-up Form -Cerebral rSO2

    Second measurement- 15. minutes after the intervention (T1)

  • Physiologic Parameter Follow-up Form -Cerebral rSO2

    Second measurement- 30. minutes after the intervention (T1)

  • Physiologic Parameter Follow-up Form -Oxygen saturation (sPO2)

    Second measurement- 5. minutes after the intervention (T1)

  • Physiologic Parameter Follow-up Form -Oxygen saturation (sPO2)

    Second measurement- 15. minutes after the intervention (T1)

  • +12 more secondary outcomes

Study Arms (2)

Intranasal Breast Milk Group

EXPERIMENTAL

Preterm infants (28-37 gestation week) in the intervention group will receive 0.2 ml of breast milk intranasally three times a day for three days.

Other: Intranasal human breast milk

Control Group

NO INTERVENTION

Preterm newborns in the control group will not receive any intervention.

Interventions

The information in the "Physiologic Parameter Follow-up Form" will be recorded by the investigator just 5 minutes before the intervention. The researcher will drip 0.2 ml of breast milk at room temperature (approximately 22 °C) into the nose of the infant lying in the supine position, 0.1 ml in the right nose-0.1 ml in the left nose. 5 minutes after the intervention (T1), 15 minutes after the intervention (T2) and 30 minutes after the intervention (T3), the data in the "Physiologic Parameter Follow-up Form" will be recorded by the researcher. After intranasal breast milk administration, the baby will be fed by the neonatal nurse as in routine practice. The implementation of the intervention in the study will last for three days and this process will be repeated three times every day (09.00, 12.00 and 15.00).

Intranasal Breast Milk Group

Eligibility Criteria

Age28 Weeks - 37 Weeks
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17)

You may qualify if:

  • Birth weight \>1000 gr,
  • APGAR score \>7 at 5 minutes after birth,
  • Availability of breast milk,
  • No medical diagnosis affecting cerebral oxygenation (intraventricular hemorrhage, cardiovascular and neurological disorders, anemia),
  • No congenital anomalies or chromosomal abnormalities,
  • No congenital anomaly (such as cleft palate) affecting nasal patency.

You may not qualify if:

  • Being able to feed orally in all feedings
  • Being fed entirely on formula milk,
  • Administration of medication via the nasal route,
  • Being intubated or receiving continuous positive air pressure (CPAP) support,
  • Maternal substance abuse, alcohol abuse, HIV infection, untreated active tuberculosis, chemotherapy or radiotherapy treatment,
  • The mother has mastitis, breast trauma, abscesses or is taking any medication that passes into the milk,
  • The mother does not want to express milk.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Selcuk University

Konya, Turkey (Türkiye)

RECRUITING

Related Publications (5)

  • Keller T, Korber F, Oberthuer A, Schafmeyer L, Mehler K, Kuhr K, Kribs A. Intranasal breast milk for premature infants with severe intraventricular hemorrhage-an observation. Eur J Pediatr. 2019 Feb;178(2):199-206. doi: 10.1007/s00431-018-3279-7. Epub 2018 Nov 1.

    PMID: 30386923BACKGROUND
  • Hoban R, Gallipoli A, Signorile M, Mander P, Gauthier-Fisher A, Librach C, Wilson D, Unger S. Feasibility of intranasal human milk as stem cell therapy in preterm infants with intraventricular hemorrhage. J Perinatol. 2024 Nov;44(11):1652-1657. doi: 10.1038/s41372-024-01982-8. Epub 2024 Apr 30.

    PMID: 38688998BACKGROUND
  • Muelbert M, Alexander T, Pook C, Jiang Y, Harding JE, Bloomfield FH. Cortical Oxygenation Changes during Gastric Tube Feeding in Moderate- and Late-Preterm Babies: A NIRS Study. Nutrients. 2021 Jan 25;13(2):350. doi: 10.3390/nu13020350.

    PMID: 33503882BACKGROUND
  • Yucel A, Kucukoglu S, Soylu H. The Effect of Breast Milk Odor on Feeding Cues, Transition Time to Oral Feeding, and Abdominal Perfusion in Premature Newborns: A Randomised Controlled Trial. Biol Res Nurs. 2024 Jan;26(1):160-175. doi: 10.1177/10998004231200784. Epub 2023 Sep 8.

    PMID: 37682253BACKGROUND
  • Yucel A, Kucukoglu S, Konak M. The Effect of Intranasal Breast Milk Administration on Cerebral Oxygenation, Vital Signs and Time to Full Oral Feeding in Preterm Infants: a Randomised Controlled Study Protocol. Nurs Crit Care. 2026 Jan;31(1):e70262. doi: 10.1111/nicc.70262.

MeSH Terms

Conditions

Breast FeedingPremature Birth

Condition Hierarchy (Ancestors)

Feeding BehaviorBehaviorObstetric Labor, PrematureObstetric Labor ComplicationsPregnancy ComplicationsFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital Diseases

Study Officials

  • Sibel Kucukoglu, Prof

    Selcuk University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Sibel Kucukoglu, Prof

CONTACT

Adalet Yücel, Assistant

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Randomized controlled design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Prof

Study Record Dates

First Submitted

May 21, 2024

First Posted

November 26, 2024

Study Start

June 30, 2024

Primary Completion

September 15, 2025

Study Completion

December 30, 2025

Last Updated

November 26, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

It will be shared after the article is published.

Locations